ACT Medical Supplies

  • Full Screen
  • Wide Screen
  • Narrow Screen
  • Increase font size
  • Default font size
  • Decrease font size
French (Fr)English (United Kingdom)

Vietnam Health Market

E-mail Print PDF

1VIETNAM’S PHARMACEUTICAL MARKET WAS VALUED AT AROUND US$1.53 BIL. IN 2009 AND
ESTIMATED TO REACH US$ 6.1 BIL.IN 2019

2VIETNAM’S POPULATION DYNAMICS HAS A DIRECT POSITIVE ACTION ON THIS MARKET EXPECTED
TO MATCH 100 MILLIONS INHABITANTS BEFORE END 2020

3SPENDING ON PHARMACEUTICALS IS EXPECTED TO RAISE FROM US$ 16.63 TO US$ 60.30
IN 2019 PER CAPITA.

4BY THE END OF 2008 THERE ARE 89 GOOD MANUFACTURING PRACTICE (GMP) COMPLIED MANUFACTURERS
HAVING WELL-EQUIPPED LABS.

 108 BUSINESSES ACCREDITED FOR GSP.

VIETNAM LOCAL PHARMACEUTICAL INDUSTRY WILL PLAY A CRUCIAL ROLE IN THE MARKET EXPANSION.

 LOCAL FIRMS ARE ALREADY PRODUCING 60% OF THE DOMESTIC DEMAND.

 

DRUG ADMINISTRATION VIETNAM (DAV) WILL ENFORCE ITS INFLUENCE ON:

  •  DRUG REGISTRATION
  •  DRUG PRICING
  •  DRUG DISTRIBUTION

 

DRUG IMPORT VOLUME:

  •  COUNTRIES EXPORTING MOST FINISHED PRODUCTS TO VN IN 2008:
    • FRANCE 142.50 MILLION USD
    • INDIA 104.71 MILLION USD
    • KOREA 81.51 MILLION USD
  •  COUNTRIES EXPORTING PHARMACEUTICAL RAW MATERIALS TO VIETNAM IN 2008:
    • CHINA 47.001 MILLION USD
    • INDIA 40.777 MILLION USD
    • SINGAPORE 20.004 MILLION USD

FOREIGN INVESTMENT:

  •  BY 31/12/2008, THERE ARE 37 INVESTMENT PROJECTS IN PHARMACEUTICAL FIELD NATIONWIDE.
  •  22 FDI DRUG MANUFACTURER WITH 40 PRODUCTION LINES OF GMP COMPLIED MANUFACTURERS.
You are here: About ACT Vietnam Health Market